LifeTec Group
- Company typePrivate
- Founded2004
- HeadquartersEindhoven, Netherlands
- Headcount11–50
- GTM typeB2B
- OfferingServices
LifeTec Group firmographics
Firmographics- Name
- LifeTec Group
- Legal name
- LifeTec Group BV
- Website
- https://lifetecgroup.com
- Company type
- Private
- Founded year
- 2004
- Operating status
- Acquired
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
LifeTec Group industry classification
Industry- Product category
- Preclinical Contract Research Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Services-Commercial Physical & Biological Research (8731), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Nonclinical Study Management & Regulatory Writing (IND-enabling) (HLAGAFAN)
Keywords
Where LifeTec Group is headquartered
LocationHeadquarters
- HQ city
- Eindhoven
- HQ country
- Netherlands
- HQ region
- Europe
Offices2 records
Markets served
LifeTec Group business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain
Revenue model
- Preclinical Contract Research Services: Occasional studies using BioSimulation platforms and experienced engineering team for assessment studies. Acts as extension of client's own team.
- BioSimulation Technology Sales and Lease: BioSimulation platforms available for intensive or long-term use as purchase or lease services. Includes platforms like Cardiac BioSimulator, PhysioHeart, BioLiver, OsteoChondral, and VABIO.
- BioSkills Training and Workshops: Clinical training and workshop activities to introduce new device technology to clinical end-users using BioSimulation services.
- Development and Manufacturing: Device prototyping services and full device development partnership through Resolution Medical connection. Manufacturing capabilities available for medical devices.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | — | Custom Contract Research - Quote-based pricing |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels4 records
LifeTec Group product offering
Product offeringCore offering
LifeTec Group is a preclinical contract research organization that develops and operates proprietary BioSimulation platforms using real animal tissues (slaughterhouse hearts, livers, arteries, bone/cartilage) to test and train on cardiovascular, hepatic, vascular and osteochondral medical devices under physiologically realistic conditions. It sells or leases these platforms and provides preclinical research services, clinical BioSkills training, and prototyping/manufacturing support via its parent Resolution Medical.
Product overview
LifeTec Group is a preclinical contract research organization offering a portfolio of BioSimulator platforms and related services. The core products include six BioSimulator platforms: BioLiver (ex-vivo liver perfusion), Cardiac BioSimulator (beating heart simulator), PhysioHeart™ (isolated beating heart), OsteoChondral Platform (bone/cartilage cultivation), VAscular BIOreactor (VABIO), and Heart Valve Assessment Platform. These are supported by four service offerings: Preclinical Research Services (contract research using the platforms), BioSimulation Technologies (purchase/lease access), BioSkills Training & Workshops (clinical training), and Development & Manufacturing (prototyping through Resolution Medical). The company was acquired by Resolution Medical in 2022.
Differentiator
Problem solved
Functional benefit
Quantifiable outcome
- Slaughterhouse hearts can be used as cost-effective alternative to laboratory hearts for ex-situ heart perfusion studies with 100% functional survival
- +2 more outcomes
Companies that use LifeTec Group
Customer profileNamed customers7 records
Segments3 records
Ideal customer profiles3 records
LifeTec Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
LifeTec Group partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core and minor.
- Atlantic Technological University (ATU)coreAtlantic Technological University announced collaboration with Resolution Medical and LifeTec Group to bring advanced BioSimulation technologies and device development expertise to Galway. The partnership supports startups and SMEs looking to accelerate medical device innovations. Cardiac BioSimulator demonstrations were performed in ATU's Medical Imaging Suite at the iHub.
- CoreMedicminorCoreMedic and LifeTec Group teamed up in a Eurostars-funded project aimed at advancing medical training and device development. This collaborative project focuses on enhancing medical training methodologies using biosimulation technologies.
- Resolution MedicalcoreResolution Medical, a medical device CDMO and portfolio company of Arcline Investment Management, acquired LifeTec Group in June 2022. This acquisition integrated LifeTec's biosimulation services with Resolution Medical's device development and manufacturing capabilities. LifeTec brings early device prototyping services to Resolution Medical's European facility, while Resolution Medical provides 35,000 sq. ft. R&D facility in Minneapolis with state-of-the-art biosimulation lab.
- SINERGIA ConsortiumcoreLifeTec Group participates in SINERGIA, a European research consortium focused on advanced technologies for drug discovery and precision medicine. The consortium includes 14 academic and industrial beneficiaries working on developing advanced in vitro models including ex vivo platforms. LifeTec contributes the BioLiver platform for research on liver interventions and tissue response.
- BIOGEL ConsortiumcoreLifeTec Group participates in BIOGEL, a Marie Skłodowska-Curie ITN focused on developing innovative hydrogels for biomedical applications. LifeTec contributes by creating physiologically relevant 3D in vitro and ex vivo platforms to study biomaterial behavior and tissue interaction.
- Perinatal Life Support ConsortiumcoreLifeTec Group participates in the EU-funded Perinatal Life Support project, a consortium including Eindhoven University of Technology, RWTH Aachen University, Politecnico Milano, and Nemo Healthcare. The project aims to create an artificial womb environment for premature infants. LifeTec contributes ex vivo technologies for testing oxygen and nutrient supply, cannulation, and blood circulation concepts.
- Catharina HospitalminorCollaboration with Catharina Hospital Eindhoven on research using PhysioHeart platform for studying intracoronary cooling effects on myocardial reperfusion injury.
- Eindhoven University of TechnologycoreLifeTec Group originated as spin-off from TU/e Department of Biomedical Engineering in 2004. Ongoing collaboration on research projects and technology development including cardiovascular biomechanics research.
- RegMed XBcoreLifeTec Group collaborates with RegMed XB (Regenerative Medicine Cross-Border) on cardiovascular moonshot project developing regenerative technologies for repairing failing human hearts using PhysioHeart platform.
Scale indicators6 records
Recent moves7 records
Expansion highlights6 records
LifeTec Group competitors and assessment
Company assessmentBroad incumbents
- Charles River Laboratories: Large global CRO offering preclinical research, safety assessment, and biomedical device testing services. Comparable as a broad preclinical services provider where medical device manufacturers can outsource testing, but lacks LifeTec's specialized BioSimulation niche.
- TNO (Netherlands Organisation for Applied Scientific Research): Dutch applied research organization with biomedical and medical device preclinical capabilities including organ-on-chip and bio-imaging work. Comparable as a Dutch-based applied research organization offering preclinical testing for medical devices, though operating as a public research institute.
- WuXi AppTec: Major global preclinical CRO and CDMO offering a broad range of testing and development services. Comparable as a large preclinical research services provider, but operates at a different scale and breadth than LifeTec's specialized ex vivo organ platforms.
Direct peers
- TissUse GmbH: German multi-organ-chip company developing HUMIMIC chip platforms for preclinical substance and device testing. Closely comparable as a multi-organ preclinical platform provider targeting regulatory and industrial research customers.
- CN Bio Innovations: UK-based organ-on-chip and microphysiological systems company providing preclinical in vitro models for drug development and toxicology. Directly comparable to LifeTec as an alternative preclinical platform provider using advanced biological model systems for regulated research applications.
- Emulate Inc: US organ-on-chip technology company whose Organ-Chip platforms replicate human physiology for preclinical testing of drugs, chemicals, and devices. Competes with LifeTec's ex vivo organ approach as a more standardized, higher-throughput preclinical alternative.
- Mimetas B.V. Dutch organ-on-chip company offering OrganoPlate platforms for disease modeling, toxicology, and preclinical testing. Comparable as a Netherlands-rooted in vitro model platform company targeting pharma and medical device R&D customers.
Others
- Resonetics: US-based medical device contract manufacturer specializing in interventional and neuromodulation markets that has acquired Resolution Medical (LifeTec's parent). Connected as the ultimate corporate parent rather than a direct competitor, but provides context on the integrated manufacturing pipeline LifeTec now sits within.
Emerging players
- InSilicoTrials Technologies: Italy-based computational modeling platform providing in silico clinical trials for medical devices and drugs. Comparable as an alternative preclinical evidence-generation approach competing for the same MedTech R&D budget.
- Hesperos Inc: US company developing multi-organ human-on-a-chip systems for preclinical drug and disease modeling. Comparable as a specialized organ-model platform provider, though focused primarily on drug development rather than medical device testing.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
LifeTec Group social profiles
Digital presenceLifeTec Group compliance and trust
Trust signalCompliance3 records
LifeTec Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
LifeTec Group leadership team
Management profileNumber of profiles
Profiles13 records
LifeTec Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
LifeTec Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about LifeTec Group
What does LifeTec Group do?
LifeTec Group is a preclinical contract research organization that develops and operates proprietary BioSimulation platforms using real animal tissues (slaughterhouse hearts, livers, arteries, bone/cartilage) to test and train on cardiovascular, hepatic, vascular and osteochondral medical devices under physiologically realistic conditions. It sells or leases these platforms and provides preclinical research services, clinical BioSkills training, and prototyping/manufacturing support via its parent Resolution Medical.
Is LifeTec Group a public or private company?
LifeTec Group is a private company. It is classified as private equity controlled and is currently acquired.
When was LifeTec Group founded?
LifeTec Group was founded in 2004. It employs 11 to 50 people.
Where is LifeTec Group based?
LifeTec Group is headquartered in Eindhoven, Netherlands, in the Europe region.
How does LifeTec Group make money?
Four revenue lines are on record. Preclinical Contract Research Services are the primary driver. The others are bioSimulation Technology Sales and Lease, bioSkills Training and Workshops and development and Manufacturing.
Who are LifeTec Group's main competitors?
Broad incumbents on record are Charles River Laboratories, TNO (Netherlands Organisation for Applied Scientific Research) and WuXi AppTec. Direct peers are TissUse GmbH, CN Bio Innovations, Emulate Inc and Mimetas B.V.. Resonetics is listed as an others. Emerging players are InSilicoTrials Technologies and Hesperos Inc.
Does LifeTec Group have an API?
No public API is recorded for LifeTec Group.
What industry is LifeTec Group in?
LifeTec Group's product category is Preclinical Contract Research Services. Its primary akta.pro industry code is HLAGAFAN, Nonclinical Study Management & Regulatory Writing (IND-enabling). Its NAICS code is 541714 and its SIC code is 8731.